Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03507452
Recruitment Status : Active, not recruiting
First Posted : April 25, 2018
Last Update Posted : October 15, 2021
Sponsor:
Information provided by (Responsible Party):
Bayer